Published in Cancer Weekly, September 6th, 1999
Now it is possible to create live-virus flu vaccines more effective than the cold-adapted vaccines currently in clinical trials. Such vaccines could quickly be made in response to emerging epidemics of dangerous new influenza strains. And the ability to add new genes to customized flu viruses opens a new avenue for the development of vaccines against other diseases.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.